Catalent Pharma Solutions has expanded capabilities within its European Clinical Supply Services network for specialty clinical packaging, where the proportion of highly-potent or temperature-sensitive investigational medical products continues to rise.
 
The company has tripled frozen storage (-18°C) capacity at its Schorndorf, Germany, facility, and has added a second automated Inova packaging line for pre-filled syringes, with capabilities including plunger-rod insertion, application of single panel labels, finger flanges, and safety device mounting.
 
At its controlled substances facility in Deeside, UK, the company has added a third vault, bringing the combined controlled substance storage capacity to more than 14,000 cubic feet. Additionally, the company has updated cold storage capabilities at its Bathgate, UK facility to include a cryogenic storage service, suitable for stem cells, regenerative therapies and other clinical materials.
 
Also, at Catalent’s primary packaging facility, in Bolton, UK, the company has installed two new energy-efficient chiller units that increase output capacity by more than 10%.
 
“As with our recent investments in our U.S. capabilities, we are committed to offering comprehensive clinical supply solutions throughout our European network,” said Gerry Hepburn, chief operating officer, vice president and general manager of Catalent’s Clinical Supply Services business. “A key part of that commitment is ensuring that our facilities are well aligned with the current, emerging and future needs of our customers, as evidenced by our recent investments in Europe and the harmonization of key systems across all Catalent sites.”